M. Aman

发表

Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children

E. Mitchell, M. Aman, S. Turbott, 1987, Clinical pediatrics.

The effects of essential fatty acid supplementation by efamol in hyperactive children

E. Mitchell, M. Aman, Sarah H. Turbo, 1987, Journal of abnormal child psychology.

Stimulant drug effects in developmental disorders and hyperactivity — Toward a resolution of disparate findings

M. Aman, 1982, Journal of autism and developmental disorders.

Challenges in Evaluating Psychosocial Interventions for Autistic Spectrum Disorders

Tristram H. Smith, G. Dawson, C. Lord, 2005, Journal of autism and developmental disorders.

The Repetitive Behavior Scale-Revised: Independent Validation in Individuals with Autism Spectrum Disorders

M. Aman, Kristen S. L. Lam, Michael G Aman, 2007, Journal of autism and developmental disorders.

Development of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP).

C. Farmer, M. Aman, 2009, Research in developmental disabilities.

Psychometric properties of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP).

C. Farmer, M. Aman, 2010, Research in developmental disabilities.

Confirmation of the Factor Structure and Measurement Invariance of the Children's Scale of Hostility and Aggression: Reactive/Proactive in Clinic-Referred Children With and Without Autism Spectrum Disorder.

E. Cook, J. Lainhart, C. Farmer, 2016, Journal of child and adolescent psychopharmacology.

Effects of Methylphenidate in Normal Adults with Reference to Drug Action in Hyperactivity

M. Aman, J. Werry, M. Vamos, 1984, The Australian and New Zealand journal of psychiatry.

Patterns of Drug Use, Methodological Considerations, Measurement Techniques, and Future Trends

Nirbhay N. Singh, M. Aman, 1988 .

Population Pharmacokinetic Modeling of Risperidone and 9-Hydroxyrisperidone to Estimate CYP2D6 Subpopulations in Children and Adolescents

R. Bies, A. Vinks, M. Aman, 2012, Therapeutic drug monitoring.

Research knowledge among parents of children participating in a randomized clinical trial.

C. McDougle, J. McCracken, L. Scahill, 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.

R. Findling, M. Aman, G. de Smedt, 2002, The American journal of psychiatry.

The psychometric characteristics of the preschool behavior questionnaire in preschoolers with developmental handicaps

J. Rojahn, M. Aman, 1994 .

Methylphenidate and haloperidol in children. Effects on attention, memory, and activity.

M. Aman, J. Werry, 1975, Archives of general psychiatry.

Reactions to “Ethical challenges and complexities of including people with intellectual disability as participants in research” by Dr Teresa Iacono

B. Handen, M. Aman, 2006 .

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.

C. McDougle, D. Posey, F. Volkmar, 2000, Child and adolescent psychiatric clinics of North America.

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

M. Aman, 2004, Seminars in pediatric neurology.

Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity.

C. McDougle, D. Posey, L. Ritz, 2010, Journal of child and adolescent psychopharmacology.

Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies

R. Palmer, A. Hardan, M. Aman, 2019, Autism : the international journal of research and practice.

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

M. Aman, C. Binder, A. Turgay, 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

Gastrointestinal Symptoms in a Sample of Children with Pervasive Developmental Disorders

C. McDougle, D. Posey, L. Ritz, 2009, Journal of autism and developmental disorders.

Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry.

D. Svinarov, M. Aman, P. Vouros, 2004, Journal of chromatography. A.

Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents

M. Aman, A. J. White, Anthony J. White, 1988, Journal of autism and developmental disorders.

Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.

Xiaobai Li, C. Farmer, B. Molina, 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation.

L. Rohde, M. Aman, Alceu Gomes Correia Filho, 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

Safety and Efﬁcacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension

R. Palmer, A. Hardan, R. Findling, 2016 .

Pharmacotherapy of disorders in mental retardation

M. Aman, R. Lindsay, A. Collier-Crespin, 2009, European Child & Adolescent Psychiatry.

The usefulness of thioridazine for treating childhood disorders--fact or folklore?

M. Aman, N. Singh, 1980, American journal of mental deficiency.

Psychopharmacology of the developmental disabilities

M. Aman, N. S. Nirbhay, 1988 .

Recent Studies in Psychopharmacology in Mental Retardation

M. Aman, 1997 .

Prevalence and pattern of prescribed medication in 2-year-old children

J. Rojahn, M. Aman, E. Marshburn, 1994 .

Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects.

R. A. Kern, D. McGhee, L. E. Arnold, 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

Beta blockers in mental retardation and developmental disorders.

L. E. Arnold, M. Aman, L. Arnold, 1991, Journal of child and adolescent psychopharmacology.

Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

S. Merry, M. Aman, S. Turbott, 1991, Journal of the American Academy of Child and Adolescent Psychiatry.

Considerations in the use of psychotropic drugs in elderly mentally retarded persons.

M. Aman, 2008, Journal of mental deficiency research.

Medication use in an ICF/MR for nonambulatory severely and profoundly mentally retarded children

M. Aman, J. Mulick, J. Dura, 1988 .

The relationship between nurse characteristics and perceptions of psychotropic medications in residential facilities for the retarded

Nirbhay N. Singh, M. Aman, J. Fitzpatrick, 1987, Journal of autism and developmental disorders.

Caregiver perceptions of psychotropic medication in residential facilities.

M. Aman, N. Singh, A. J. White, 1987, Research in developmental disabilities.

Drugs in Mental Retardation: Treatment or Tragedy?.

M. Aman, 1985 .

The psychopathology instrument for mentally retarded adults: psychometric characteristics, factor structure, and relationship to subject characteristics.

Nirbhay N. Singh, M. Aman, N. Singh, 1988, Research in developmental disabilities.

Haloperidol and methylphenidate in hyperactive children.

M. Aman, J. Werry, E. Lampen, 1976, Acta paedopsychiatrica.

The aberrant behavior checklist: factor structure and the effect of subject variables in American and New Zealand facilities.

M. Aman, R. Kissel, A. W. Stewart, 1987, American journal of mental deficiency.

Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression.

C. Farmer, B. Molina, R. Findling, 2019, Journal of child and adolescent psychopharmacology.

Review of fenfluramine in the treatment of the developmental disabilities.

R. A. Kern, M. Aman, 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients--a pilot study.

M. Aman, A. J. White, C. Field, 2008, Journal of mental deficiency research.

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

M. Aman, N. Singh, A. W. Stewart, 1985, American journal of mental deficiency.

Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study.

Tristram H. Smith, J. Hellings, X. Pan, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Assessing change in core autism symptoms: challenges for pharmacological studies.

L. E. Arnold, M. Aman, Jill Hollway, 2015, Journal of child and adolescent psychopharmacology.

Four-year follow-up of children with low intelligence and ADHD: a replication.

M. Aman, S. Armstrong, B. Buican, 2002, Research in developmental disabilities.

Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects.

R. A. Kern, J. Rojahn, M. Aman, 1997, American journal of mental retardation : AJMR.

Prediction of clinical response in children taking methylphenidate

M. Aman, S. Turbott, Sarah H. Turbott, 1991, Journal of autism and developmental disorders.

Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.

C. Farmer, B. Molina, R. Findling, 2015, Journal of child and adolescent psychopharmacology.

The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders.

C. Farmer, B. Molina, R. Findling, 2017, Journal of child and adolescent psychopharmacology.

Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.

C. Farmer, B. Molina, R. Findling, 2015, Journal of child and adolescent psychopharmacology.

What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder?

Xiaobai Li, C. Farmer, B. Molina, 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

What Does Risperidone Add to Stimulant and Parent Training for Severe Aggression in Child Attention-Deficit / Hyperactivity Disorder ?

Xiaobai Li, C. Farmer, B. Molina, 2014 .

Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism

C. McDougle, D. Posey, J. McCracken, 2007, Biological Psychiatry.

Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.

L. E. Arnold, M. Aman, B. Buican, 2003, Journal of child and adolescent psychopharmacology.

A review of atomoxetine effects in young people with developmental disabilities.

Tristram H. Smith, X. Pan, L. E. Arnold, 2014, Research in developmental disabilities.

Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, R. Andridge, L. E. Arnold, 2017, Journal of child and adolescent psychopharmacology.

Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings.

C. Farmer, B. Molina, R. Findling, 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

Beware of Over-Interpreting Negative Trials

C. McDougle, J. McCracken, L. Scahill, 2008, Journal of autism and developmental disorders.

Adaptive Behavior Function in Autism: Association with ADHD and ASD Symptoms

D. Lane, K. Loveland, D. Pearson, 2022, Journal of Developmental and Physical Disabilities.

Comment on “hyperactivity: Nature of the syndrome and its natural history”

M. Aman, S. Sandberg, 1985, Journal of autism and developmental disorders.

Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials

J. Leblanc, M. Aman, C. Binder, 2005, International clinical psychopharmacology.

High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.

D. Lane, K. Loveland, D. Pearson, 2012, Journal of child and adolescent psychopharmacology.

Psychotropic Medicines and Aggressive Behavior

M. Aman, R. Lindsay, 2002 .

Vitamin, Mineral, and Dietary Treatments

M. Aman, Nirbhay Singh, 1988 .

Project MED: effects of a Medication EDucation booklet series for individuals with intellectual disabilities.

C. Farmer, M. Aman, B. Benson, 2007, Intellectual and developmental disabilities.

Moderators of Parent Training for Disruptive Behaviors in Young Children with Autism Spectrum Disorder

Luc Lecavalier, Karen Bearss, Tristram Smith, 2016, Journal of Abnormal Child Psychology.

Hyperactivity: Nature of the syndrome and its natural history

M. Aman, 1984, Journal of autism and developmental disorders.

Empirical classification of behavioral and psychiatric problems in children and adolescents with mental retardation.

M. Aman, L. Lecavalier, Elaine C. Brown, 2004, American journal of mental retardation : AJMR.

The Aberrant Behavior Checklist and the Behavior Problems Inventory: convergent and divergent validity.

J. Rojahn, J. Matson, M. Aman, 2003, Research in developmental disabilities.

Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation.

R. Findling, L. E. Arnold, O. Bukstein, 2020, Journal of child and adolescent psychopharmacology.

Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ.

J. Buitelaar, M. Aman, C. Binder, 2005, Journal of child and adolescent psychopharmacology.

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Xiaobai Li, C. Farmer, L. E. Arnold, 2012, Journal of child and adolescent psychopharmacology.

Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.

J. Epstein, C. Farmer, B. Molina, 2017, Journal of child and adolescent psychopharmacology.

The treatment of severe child aggression (TOSCA) study: Design challenges

Xiaobai Li, C. Farmer, R. Findling, 2011, Child and adolescent psychiatry and mental health.

Imipramine and methylphenidate in hyperactive children.

M. Aman, J. Werry, E. Diamond, 1980, Journal of child psychology and psychiatry, and allied disciplines.

Methylphenidate in Hyperactive and Enuretic Children

M. Aman, J. Werry, 1984 .

Iron homeostasis during risperidone treatment in children and adolescents.

C. McDougle, J. McCracken, L. Scahill, 2015, The Journal of clinical psychiatry.

Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial.

C. Farmer, B. Molina, R. Findling, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Psychotropic Drugs and Learning Problems—A Selective Review

M. Aman, 1980, Journal of learning disabilities.

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.

C. McDougle, J. McCracken, Andrés Martin, 2004, The American journal of psychiatry.

Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.

C. McDougle, J. McCracken, L. Scahill, 2017, Journal of child and adolescent psychopharmacology.

Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder

Tristram H. Smith, X. Pan, L. E. Arnold, 2017, Journal of Autism and Developmental Disorders.

Moderators of Parent Training for Disruptive Behaviors in Young Children with Autism Spectrum Disorder

Tristram H. Smith, L. Scahill, J. Dziura, 2016, Journal of Abnormal Child Psychology.

Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders

J. Bregman, C. McDougle, E. Hollander, 2013, Journal of Autism and Developmental Disorders.

Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders

C. McDougle, S. White, L. Scahill, 2012, Journal of Developmental and Physical Disabilities.

THE STATE-DEPENDENT EFFECTS OF METHYLPHENIDATE AND DEXTROAMPHETAMINE

R. Sprague, M. Aman, 1974, The Journal of nervous and mental disease.

Psychotropic Medication Research in Children and Adolescents: Empirical Findings and Ethical Implications

C. Farmer, M. Aman, 2008, Journal of empirical research on human research ethics : JERHRE.

Consumer satisfaction with involvement in drug research: a social validity study.

M. Aman, P. L. Wolford, 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior.

M. Aman, N. Singh, 1982, Applied research in mental retardation.

Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study

C. McDougle, D. Posey, J. McCracken, 2006, Journal of intellectual & developmental disability.

Parent-Rated Anxiety Symptoms in Children with Pervasive Developmental Disorders: Frequency and Association with Core Autism Symptoms and Cognitive Functioning

Luc Lecavalier, Benedetto Vitiello, Lawrence Scahill, 2008, Journal of abnormal child psychology.

Parent- and self-ratings of anxiety in children with mental retardation: agreement levels and test-retest reliability.

M. Aman, G. Sarphare, 1996, Research in developmental disabilities.

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

L. E. Arnold, M. Aman, Yaser Ramadan, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Correlates and Risk Markers for Sleep Disturbance in Participants of the Autism Treatment Network

E. Butter, M. Aman, Jill Hollway, 2013, Journal of Autism and Developmental Disorders.

Methylphenidate in Children: Effects upon Cardiorespiratory Function on Exertion

M. Aman, J. Werry, 1975 .

Risk Factors for Overweight in Children with Autism Spectrum Disorder

M. Aman, S. Grondhuis, 2016, Journal of Developmental and Physical Disabilities.

Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.

A. Vinks, M. Aman, Yaser Ramadan, 2007, Clinical therapeutics.

Validity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder

M. Aman, L. Lecavalier, A. Kaat, 2013, Journal of Autism and Developmental Disorders.

The Nisonger Child Behavior Rating Form: age and gender effects and norms.

J. Rojahn, M. Aman, M. Tassé, 1996, Research in developmental disabilities.

ADHD severity as a predictor of cognitive task performance in children with Autism Spectrum Disorder (ASD).

D. Lane, K. Loveland, D. Pearson, 2021, Research in developmental disabilities.

Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures

C. McDougle, D. Posey, J. McCracken, 2007, Biological Psychiatry.

A prospective open trial of guanfacine in children with pervasive developmental disorders.

C. McDougle, D. Posey, L. Ritz, 2006, Journal of child and adolescent psychopharmacology.

Risperidone in children with autism and serious behavioral problems.

C. McDougle, D. Posey, F. Volkmar, 2002, The New England journal of medicine.

Assessment in Multisite Randomized Clinical Trials of Patients with Autistic Disorder: The Autism RUPP Network

C. McDougle, D. Posey, R. Asarnow, 2000, Journal of autism and developmental disorders.

Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents

M. Aman, J. Werry, 1993, Springer US.

Neurochemical correlates of autistic disorder: a review of the literature.

L. E. Arnold, M. Aman, Kristen S. L. Lam, 2006, Research in developmental disabilities.

Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism.

Tristram H. Smith, J. Hellings, X. Pan, 2017, Journal of child and adolescent psychopharmacology.

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.

C. McDougle, D. Posey, J. McGough, 2005, The American journal of psychiatry.

Behavior of Children with Seizures Comparison with Norms and Effect of Seizure Type

M. Aman, S. Turbott, J. Werry, 1992, Journal of Nervous and Mental Disease.

The Aberrant Behavior Checklist-Community: factor validity and effect of subject variables for adults in group homes.

M. Aman, P. L. Wolford, W. H. Burrow, 1995, American journal of mental retardation : AJMR.

Effects of Phenytoin on Cognitive‐Motor Performance in Children as a Function of Drug Concentration, Seizure Type, and Time of Medication

M. Aman, S. Turbott, J. Werry, 1994, Epilepsia.

Effects of Reinforcement Contingencies on Performance of Children with Mental Retardation and Attention Problems

J. Rojahn, M. Aman, Mary Beth Dewitt, 1997 .

Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.

R. Andridge, J. Hellings, M. Butler, 2015, Journal of child and adolescent psychopharmacology.

Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education.

S. Havercamp, M. Aman, Elaine C. Brown, 2002, Research in developmental disabilities.

The international consensus process on psychopharmacology and intellectual disability.

S. Reiss, M. Aman, 1997, Journal of intellectual disability research : JIDR.

Pharmacogenetics of Metformin for Medication-Induced Weight Gain in Autism Spectrum Disorder.

E. Anagnostou, J. Veenstra-VanderWeele, James Chan, 2019, Journal of child and adolescent psychopharmacology.

Dr. Handen et al. Reply.

E. Anagnostou, J. Veenstra-VanderWeele, B. Handen, 2018, Journal of the American Academy of Child and Adolescent Psychiatry.

A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.

J. Brian, E. Anagnostou, J. Veenstra-VanderWeele, 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.

J. Brian, E. Anagnostou, J. Veenstra-VanderWeele, 2016, JAMA psychiatry.

Risperidone Dosing in Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study

Jaskaran Singh, M. Aman, S. Ness, 2012, Journal of Autism and Developmental Disorders.

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

R. Mcquade, G. Manos, M. Aman, 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

Reliability and Validity of an Assessment Instrument for Anxiety, Depression, and Mood Among Individuals with Mental Retardation

Johannes Rojahn, J. Rojahn, A. Esbensen, 2003, Journal of autism and developmental disorders.

Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder

G. Dawson, E. Cook, B. King, 2015, Autism : the international journal of research and practice.

Medication use by adolescents and adults with fragile X syndrome

J. Greenberg, Jinkuk Hong, M. Aman, 2018, Journal of intellectual disability research : JIDR.

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions

J. Buitelaar, D. Pine, S. Tyano, 2004, European Neuropsychopharmacology.

Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation

M. Aman, E. Marshburn, 1992, Journal of autism and developmental disorders.

A critical appraisal of recent drug research in mental retardation: the Coldwater studies.

M. Aman, N. Singh, 2008, Journal of mental deficiency research.

Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies.

E. Coccaro, C. Ferris, E. Youngstrom, 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

Pharmacotherapy for Hyperactivity in Children with Autism and Other Pervasive Developmental Disorders

M. Aman, Kristen Langworthy, 2000, Journal of autism and developmental disorders.

Monitoring and Measuring Drug Effects. II. Behavioral, Emotional, and Cognitive Effects

D. Pearson, M. Aman, 1993 .

The Nisonger CBRF: a child behavior rating form for children with developmental disabilities.

J. Rojahn, M. Aman, M. Tassé, 1996, Research in developmental disabilities.

Review of serotonergic agents and perseverative behavior in patients with developmental disabilities

L. E. Arnold, M. Aman, S. Armstrong, 1999 .

Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder.

David F. Bicard, Sayaka Endo, Nancy A Neef, 2005, Journal of applied behavior analysis.

Behavioral assessment of impulsivity: a comparison of children with and without attention deficit hyperactivity disorder.

Sunhwa Jung, David F. Bicard, Sayaka Endo, 2005, Journal of applied behavior analysis.

Risk Factors for Overweight in Children with Autism Spectrum Disorder

M. Aman, S. Grondhuis, 2017 .

Factor Analysis of the Nisonger Child Behavior Rating Form in Children with Autism Spectrum Disorders

M. Aman, L. Lecavalier, D. Hammer, 2004, Journal of autism and developmental disorders.

Issues in the taxonomy of psychopathology in mental retardation

S. Einfeld, M. Aman, S L Einfeld, 1995, Journal of autism and developmental disorders.

Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions.

M. Aman, S. Turbott, N. Singh, 1987, American journal of mental deficiency.

Psychometric characteristics of the aberrant behavior checklist.

M. Aman, N N Singh, M G Aman, 1985, American journal of mental deficiency.

A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders

J. Greenberg, M. Seltzer, A. Esbensen, 2009, Journal of autism and developmental disorders.

Psychometric characteristics of the aberrant behavior checklist in a well-defined sample of youth with autism Spectrum disorder

M. Mazurek, E. Butter, Jessica F. Scherr, 2019, Research in Autism Spectrum Disorders.

Risperidone and adaptive behavior in children with autism.

Susan K. Williams, C. McDougle, D. Posey, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.

C. McDougle, D. Posey, F. Volkmar, 2005, The American journal of psychiatry.

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

M. Aman, C. Binder, A. Turgay, 2004, Journal of child and adolescent psychopharmacology.

Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

R. Findling, M. Aman, A. Derivan, 2004, The American journal of psychiatry.

Sleep correlates of pervasive developmental disorders: a review of the literature.

M. Aman, Jill Hollway, Jill A. Hollway, 2011, Research in developmental disabilities.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

C. McDougle, D. Posey, J. McGough, 2005, Archives of general psychiatry.

Medication patterns in patients with autism: temporal, regional, and demographic influences.

M. Aman, Kristen S. L. Lam, M. V. Van Bourgondien, 2005, Journal of child and adolescent psychopharmacology.

Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist.

C. McDougle, S. White, B. King, 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

Risperidone in the management of disruptive behavior disorders.

R. Findling, M. Aman, G. Pandina, 2006, Journal of child and adolescent psychopharmacology.

Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.

M. Aman, G. Sarphare, W. H. Burrow, 1995, American journal of mental retardation : AJMR.

Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy.

S. Foote, M. Aman, J. Paxton, 1986, American journal of mental deficiency.

Pharmacological Intervention for Disruptive Behaviors in Intellectual and Developmental Disabilities: The Glass is Half Full

C. Farmer, M. Aman, 2013 .

Prevalence and Patterns of Use of Psychoactive Medicines Among Individuals with Autism in the Autism Society of Ohio

M. Aman, Kristen S. L. Lam, A. Collier-Crespin, 2003, Journal of autism and developmental disorders.

City-wide survey of drug patterns among non-institutionalized mentally retarded persons.

M. Aman, C. Field, G. Bridgman, 1985, Applied research in mental retardation.

Evaluation of screening tools for dementia in older adults with mental retardation.

Paul Patti, K. Loveland, M. Aman, 2004, American journal of mental retardation : AJMR.

Review and evaluation of instruments for assessing emotional and behavioural disorders

M. Aman, 1991 .

Overview of pharmacotherapy: current status and future directions.

M. Aman, 2008, Journal of mental deficiency research.

Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder

G. Dawson, E. Cook, B. King, 2013, Journal of Autism and Developmental Disorders.

Validity of the autism diagnostic interview-revised.

C. McDougle, D. Posey, J. McCracken, 2006, American journal of mental retardation : AJMR.

Outcome Measures for Clinical Drug Trials in Autism

M. Gernsbacher, B. King, D. Pearson, 2004, CNS Spectrums.

Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems.

C. McDougle, J. McCracken, L. Scahill, 2014, Child and adolescent psychiatric clinics of North America.

Risperidone Dosing in Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study

Jaskaran Singh, M. Aman, S. Ness, 2012, Journal of Autism and Developmental Disorders.

Challenges for Child and Adolescent Psychiatric Research in the Era of COVID-19.

D. Pearson, M. Aman, 2020, Journal of child and adolescent psychopharmacology.

Factor Structure of the Aberrant Behavior Checklist in Individuals with Fragile X Syndrome: Clarifications and Future Guidance.

H. Andrews, C. Erickson, M. Aman, 2020, Journal of child and adolescent psychopharmacology.

C. McDougle, F. Volkmar, J. Leckman, 2011, Journal of child and adolescent psychopharmacology.

Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.

H. Kraemer, C. McDougle, D. Posey, 2010, Journal of child and adolescent psychopharmacology.

Acute and long-term safety and tolerability of risperidone in children with autism.

C. McDougle, D. Posey, J. McGough, 2005, Journal of child and adolescent psychopharmacology.

Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies

C. McDougle, D. Posey, L. Ritz, 2013, Translational Psychiatry.

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

L Eugene Arnold, Jill Hollway, C. Farmer, 2008, Child and adolescent psychiatric clinics of North America.

Validity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder

M. Aman, L. Lecavalier, A. Kaat, 2014, Journal of autism and developmental disorders.

Validity of the Aberrant Behavior Checklist in a Clinical Sample of Toddlers

M. Aman, K. Karabekiroğlu, 2009, Child psychiatry and human development.

Atypical antipsychotics in persons with developmental disabilities

M. Aman, A. Madrid, 1999 .

Effects of Carbamazepine on Psychomotor Performance in Children as a Function of Drug Concentration, Seizure Type, and Time of Medication

M. Aman, S. Turbott, J. Werry, 1990, Epilepsia.

Ecobehavioral Analysis of Pharmacotherapy

Nirbhay N. Singh, M. Aman, 1990 .

Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.

R. Mcquade, R. Mankoski, G. Manos, 2011, Journal of child and adolescent psychopharmacology.

Positive Effects of Methylphenidate on Social Communication and Self-Regulation in Children with Pervasive Developmental Disorders and Hyperactivity

C. McDougle, D. Posey, L. Ritz, 2009, Journal of autism and developmental disorders.

Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders

C. McDougle, D. Posey, J. McCracken, 2013, The Pharmacogenomics Journal.

Pharmacotherapy in the developmental disabilites: New developments

M. Aman, 1991 .

Effect of Sodium Valproate on Psychomotor Performance in Children as a Function of Dose, Fluctuations in Concentration, and Diagnosis

M. Aman, S. Turbott, J. Werry, 1987, Epilepsia.

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.

C. McDougle, M. Davies, L. Scahill, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Stimulant drugs in the developmental disabilities revisited

M. Aman, 1996 .

Psychometric evaluation of a measure of cognitive decline in elderly people with mental retardation.

J. Rojahn, M. Aman, J. Shultz, 1998, Research in developmental disabilities.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

C. McDougle, D. Posey, H. Nagaraja, 2015, Journal of child and adolescent psychopharmacology.

Effects of thioridazine dosage on the behavior of severely mentally retarded persons.

M. Aman, N. Singh, 1981, American journal of mental deficiency.

Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

D. Lane, K. Loveland, D. Pearson, 2020, Journal of child and adolescent psychopharmacology.

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, J. Hellings, X. Pan, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

D. Lane, K. Loveland, D. Pearson, 2013, Journal of child and adolescent psychopharmacology.

Effect of Parent Training on Adaptive Behavior in Children With Autism Spectrum Disorder and Disruptive Behavior: Results of a Randomized Trial.

Tristram H. Smith, L. Scahill, J. Dziura, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial.

Luc Lecavalier, Karen Bearss, Eric Butter, 2015, JAMA.

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial.

C. McDougle, L. Ritz, L. Scahill, 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

Four-year follow-up of children with low intelligence and ADHD.

J. Rojahn, B. Handen, M. Aman, 1996, Research in developmental disabilities.

Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: Laboratory effects

R. A. Kern, D. McGhee, M. Aman, 1993, Journal of autism and developmental disorders.

Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.

M. Aman, S. Turbott, A. J. White, 1989, American journal of mental retardation : AJMR.

A Double-Blind, Placebo-Controlled Trial of Oral Human Immunoglobulin for Gastrointestinal Dysfunction in Children with Autistic Disorder

C. McDougle, B. Handen, J. Bruss, 2009, Journal of autism and developmental disorders.

Aberrant Behavior Checklist: Current Identity and Future Developments

Michael G. Aman, M. Aman, 2012 .

Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance.

S. Merry, M. Aman, S. Turbott, 1991, Journal of the American Academy of Child and Adolescent Psychiatry.

Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials

C. McDougle, J. McCracken, L. Scahill, 2012, Journal of Autism and Developmental Disorders.

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

C. McDougle, L. Ritz, L. Scahill, 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

Impact of Recent Findings on Study Design of Future Autism Clinical Trials

E. Hollander, A. Phillips, D. Guthrie, 2004, CNS Spectrums.

Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina.

M. Aman, K. S. Langworthy-Lam, M. V. Van Bourgondien, 2002, Journal of child and adolescent psychopharmacology.

No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.

C. McDougle, J. McCracken, L. Scahill, 2015, Journal of child and adolescent psychopharmacology.

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

C. McDougle, D. Posey, F. Volkmar, 2001, Journal of child and adolescent psychopharmacology.

Anxiolytics, Sedatives, and Miscellaneous Drugs

M. Aman, J. Werry, 1999 .

A Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges.

Tristram H. Smith, Xiaobai Li, X. Pan, 2014, Research in autism spectrum disorders.

Pharmacologic therapies aid treatment for autism.

M. Aman, R. Lindsay, 2003, Pediatric annals.

Pimozide Treatment in Disruptive Severely Retarded Patients

M. Aman, Tony J. R. White, 1985, The Australian and New Zealand journal of psychiatry.

Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment.

M. Aman, N. Singh, 2008, Journal of mental deficiency research.

Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders.

A. Gelenberg, R. Wright, M. Riddle, 2009, Journal of child and adolescent psychopharmacology.

Development of the Parent-Rated Anxiety Scale for Youth With Autism Spectrum Disorder.

Judith S Miller, R. Schultz, J. Herrington, 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder

Tristram H. Smith, C. McDougle, E. Hollander, 2021, Journal of Child and Family Studies.

An exploration of concomitant psychiatric disorders in children with autism spectrum disorder.

Tristram H. Smith, C. McDougle, B. King, 2019, Comprehensive psychiatry.

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension

R. Palmer, A. Hardan, R. Findling, 2017, Journal of child and adolescent psychopharmacology.

Using qualitative methods to guide scale development for anxiety in youth with autism spectrum disorder

Judith S Miller, R. Whittemore, L. Scahill, 2016, Autism : the international journal of research and practice.

Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders

J. Bregman, C. McDougle, E. Hollander, 2013, Journal of Autism and Developmental Disorders.

Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems

C. McDougle, L. Scahill, C. Farmer, 2011, Journal of Autism and Developmental Disorders.

Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems

C. McDougle, L. Scahill, C. Farmer, 2011, Journal of Autism and Developmental Disorders.

Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials

C. McDougle, L. Scahill, E. Butter, 2009, Journal of intellectual & developmental disability.

Correlates and Risk Markers for Sleep Disturbance in Participants of the Autism Treatment Network

E. Butter, M. Aman, Jill Hollway, 2013, Journal of autism and developmental disorders.

Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.

M. Aman, M. Bourgondien, G. Sarphare, 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

Psychotropic Medicines and Aggressive Behavior Part II: Antipsychotics and Mood Stabilizers

M. Aman, R. Lindsay, 2003 .

Differences in verbal and nonverbal IQ test scores in children with autism spectrum disorder

C. McDougle, L. Scahill, L. E. Arnold, 2018 .

Developmental Disabilities Modification of the Children’s Global Assessment Scale

C. McDougle, L. Scahill, L. E. Arnold, 2007, Biological Psychiatry.

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.

Susan K. Williams, C. McDougle, D. Posey, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder.

A. Gelenberg, R. Wright, M. Aman, 2009, Journal of child and adolescent psychopharmacology.

Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children.

L. E. Arnold, M. Aman, Jill Hollway, 2009, Research in developmental disabilities.

Knowledge, attitudes, and happiness of nurses working with gerontological patients.

M. Aman, L. A. Glasspoole, 1990, Journal of gerontological nursing.

Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature.

M. Aman, Jill Hollway, Jill A. Hollway, 2011, Research in developmental disabilities.

Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.

C. McDougle, J. McCracken, S. Caprio, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Discontinuation of Risperidone and Reversibility of Weight Gain in Children with Disruptive Behavior Disorders

M. Aman, S. Leone, R. Lindsay, 2004, Clinical pediatrics.

Methylphenidate and diazepam in severe reading retardation.

M. Aman, J. Werry, 1982, Journal of the American Academy of Child Psychiatry.

Children's reading disorders: problems of definition and a two‐year follow‐up

M. Aman, J. Werry, 1982, Australian paediatric journal.

Consistency of Cognitive and Motor Performance Measures over Two Years in Reading Retarded Children

M. Aman, J. Mayhew, 1980, Perceptual and motor skills.

Cognitive, social, and other correlates of specific reading retardation

M. Aman, 1979, Journal of abnormal child psychology.

Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder

G. Dawson, E. Cook, B. King, 2014, Journal of autism and developmental disorders.

Assessment of Anxiety in Children and Adolescents with Autism Spectrum Disorders.

M. Aman, S. Grondhuis, 2012 .

Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.

M. Aman, G. Gharabawi, 2004, The Journal of clinical psychiatry.

Disruptive behavior disorders in children with mental retardation.

M. Aman, B. Benson, 1999 .

Treatment planning for patients with autism spectrum disorders.

M. Aman, Michael G Aman, 2005, The Journal of clinical psychiatry.

Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder

Matthew S. Goodwin, G. Dawson, B. Leventhal, 2019, Journal of autism and developmental disorders.

Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder

Matthew S. Goodwin, G. Dawson, B. Leventhal, 2017, Journal of child and adolescent psychopharmacology.

The use of methylphenidate in autism.

M. Aman, 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

Mechanism for Testing Operant Conditioning and Body Rocking in Developmental Disabilities

M. Aman, 1984, Perceptual and motor skills.

The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action

M. Aman, J. Werry, 1975, Psychopharmacologia.

Side effects associated with psychoactive medication in individuals with autism.

M. Aman, G. Sarphare, M. V. Van Bourgondien, 1997, Journal of autism and developmental disorders.

Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use

E. Anagnostou, J. Veenstra-VanderWeele, L. E. Arnold, 2018, Journal of child and adolescent psychopharmacology.

The Nisonger Child Behavior Rating Form: typical IQ version

D. Coury, M. Aman, L. Lecavalier, 2008, International clinical psychopharmacology.

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes.

J. Lieberman, C. McDougle, S. Potkin, 2015, Pharmacogenomics.

Overweight and obesity in youth with developmental disabilities: a call to action.

M. Aman, S. Grondhuis, Michael G. Aman, 2014, Journal of intellectual disability research : JIDR.

Testing Genetic Modifiers of Behavior and Response to Atomoxetine in Autism Spectrum Disorder with ADHD

Tristram H. Smith, W. Sadee, G. Herman, 2018, Journal of Developmental and Physical Disabilities.

Testing Genetic Modifiers of Behavior and Response to Atomoxetine in Autism Spectrum Disorder with ADHD

Tristram H. Smith, W. Sadee, G. Herman, 2018, Journal of developmental and physical disabilities.

Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders

C. McDougle, S. White, L. Scahill, 2013, Journal of developmental and physical disabilities.

A single-subject study of imipramine in a mentally retarded woman with depressive symptoms.

M. Aman, A. J. White, C. Field, 2008, Journal of mental deficiency research.

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study

C. McDougle, D. Posey, J. McCracken, 2007, Psychopharmacology.

Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems

Tristram H. Smith, C. McDougle, R. Andridge, 2019, Journal of Child and Family Studies.

Factor Validity of a Proactive and Reactive Aggression Rating Scale

C. Farmer, R. Findling, L. E. Arnold, 2014, Journal of Child and Family Studies.

Factor Validity of a Proactive and Reactive Aggression Rating Scale

C. Farmer, R. Findling, L. E. Arnold, 2014, Journal of Child and Family Studies.

Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders.

Tristram H. Smith, L. Scahill, E. Butter, 2013, Neuropsychiatry.

Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.

Xiaobai Li, C. Farmer, B. Molina, 2015, Journal of child and adolescent psychopharmacology.

Trial Design Challenges When Combining Medication and Parent Training in Children with Pervasive Developmental Disorders

C. McDougle, L. Ritz, J. McCracken, 2009, Journal of autism and developmental disorders.

Cognitive effects of risperidone in children with autism and irritable behavior.

C. McDougle, D. Posey, L. Ritz, 2008, Journal of child and adolescent psychopharmacology.

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

R. Mankoski, G. Manos, S. Mathew, 2010, Journal of child and adolescent psychopharmacology.

Overweight and obese status in children with autism spectrum disorder and disruptive behavior

C. McDougle, J. McCracken, L. Scahill, 2018, Autism : the international journal of research and practice.

Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems

Tristram H. Smith, C. McDougle, R. Andridge, 2019, Journal of Child and Family Studies.

Psychometric properties of the children's sleep habits questionnaire in children with autism spectrum disorder.

Tristram H. Smith, L. Scahill, M. Aman, 2016, Sleep medicine.

Development of the Adult Scale of Hostility and Aggression: Reactive-Proactive (A-SHARP).

M. Aman, S. Matlock, Scott T. Matlock, 2011, American journal on intellectual and developmental disabilities.

Standardized Observation Analogue Procedure in the Treatment of Severe Childhood Aggression Study.

C. Farmer, B. Molina, R. Findling, 2019, Journal of child and adolescent psychopharmacology.

Psychometric Properties of the Norwegian Aberrant Behavior Checklist and Diagnostic Relationships in a Neuro-Pediatric Sample

M. Martinussen, M. Aman, Oddmar Ole Steinsvik, 2019, Journal of Mental Health Research in Intellectual Disabilities.

Varenicline in autistic disorder: hypothesis and case report of single-patient crossover.

L. E. Arnold, M. Aman, Rene Anand, 2013, Journal of child and adolescent psychopharmacology.

Aggressive behavior in a sample of children with autism spectrum disorders

Cristan Farmer, Michael G. Aman, C. Farmer, 2011 .

Factor Structure and Norms for the Revised Behavior Problem Checklist in New Zealand Children

M. Aman, J. Werry, Malcolm Lowe, 1983, The Australian and New Zealand journal of psychiatry.

Incidental learning, distraction, and sustained attention in hyperactive and control subjects

M. Aman, Sarah H. Turbott, S. Turbott, 1986, Journal of abnormal child psychology.

The revised behavior problem checklist in clinic attenders and non‐attenders: Age and sex effects

M. Aman, J. Werry, 1984 .

Psychometric characteristics of the adult scale of hostility and aggression: reactive/proactive (A-SHARP) and relation to psychiatric features of adults with developmental disabilities.

M. Aman, S. Matlock, 2014, Research in developmental disabilities.

Development of a parent training program for children with pervasive developmental disorders

Susan K. Williams, Tristram H. Smith, C. McDougle, 2007 .

The reliability and diagnostic validity of the physical and neurological examination for soft signs (PANESS)

M. Aman, J. Werry, 1976, Journal of autism and childhood schizophrenia.

Ratings of hyperactivity and developmental indices: Should clinicians correct for developmental level?

D. Pearson, M. Aman, 1994, Journal of autism and developmental disorders.

Psychometric Properties of the Family Support Scale with Head Start Families

Marc J. Tassé, Michael G. Aman, Barbara Hanley, 1998 .

Aggression in children with autism spectrum disorders and a clinic-referred comparison group

E. Cook, J. Lainhart, C. Farmer, 2015, Autism : the international journal of research and practice.

Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder

Tristram H. Smith, X. Pan, L. E. Arnold, 2018, Journal of autism and developmental disorders.

Fenfluramine and mental retardation.

R. A. Kern, D. McGhee, L. E. Arnold, 1991, Journal of the American Academy of Child and Adolescent Psychiatry.

Prolactin levels in children after long term treatment with risperidone

R. Findling, M. Aman, C. Binder, 2003, Schizophrenia Research.

490. Risperidone versus placebo for severe conduct disorder in children with mental retardation

R. Findling, M. Aman, A. Derivan, 2000, Biological Psychiatry.

Biological and environmental risk for poor developmental outcome of young children.

J. Rojahn, M. Moeschberger, M. Aman, 1993, American journal of mental retardation : AJMR.

Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder

Tristram H. Smith, C. McDougle, B. King, 2016, Autism : the international journal of research and practice.

Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials

C. McDougle, J. McCracken, L. Scahill, 2013, Journal of autism and developmental disorders.

Preliminary study of imipramine in profoundly retarded residents

M. Aman, A. J. White, C. J. Teehan, 1986, Journal of autism and developmental disorders.

Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities.

M. Aman, 1993, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Assessing Psychopathology and Behavior Problems in Persons with Mental Retardation: A Review of Available Instruments.

M. Aman, 1991 .

Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.

C. McDougle, Xiaobai Li, L. Scahill, 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

The Efficacy of Folic Acid in Fragile X Syndrome and Other Developmental Disabilities

R. A. Kern, M. Aman, 1990 .

Executive Function in Autism: Association with ADHD and ASD Symptoms

D. Lane, K. Loveland, D. Pearson, 2021, Journal of Autism and Developmental Disorders.

Sensitivity of the modified Children’s Yale–Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials

C. McDougle, K. Katz, J. McCracken, 2016, Autism : the international journal of research and practice.

Developmental Disability--Children's Global Assessment Scale

C. McDougle, L. Scahill, B. Vitiello, 2015 .

Fluctuations in Salivary Carbamazepine and Carbamazepine‐10,11‐Epoxide Concentrations During the Day in Epileptic Children

M. Aman, J. Werry, J. Paxton, 1983, Epilepsia.

Assessment of the Integrity of Study Blindness in a Pediatric Clinical Trial of Risperidone

C. McDougle, D. Posey, J. McCracken, 2005, Journal of clinical psychopharmacology.

The Home Situations Questionnaire-PDD version: factor structure and psychometric properties.

C. McDougle, L. Scahill, D. Sukhodolsky, 2010, Journal of intellectual disability research : JIDR.

RUPP AUTISM NETWORK RANDOMIZED CLINICAL TRIAL OF PARENT TRAINING AND MEDICATION: ONE-YEAR FOLLOW-UP

Xiaobai Li, L. Scahill, E. Butter, 2013 .

Aripiprazole for the treatment of irritability associated with autism

C. Farmer, M. Aman, 2011, Expert opinion on pharmacotherapy.

Knowledge Among Parents of Children Participating in a Randomized Clinical Trial

C. McDougle, J. McCracken, M. Davies, 2005 .

Mental retardation: state of the field in New Zealand.

M. Aman, N. Singh, 1981, Applied research in mental retardation.

Sleep correlates of pervasive developmental disorders: a review of the literature.

M. Aman, Jill A. Hollway, 2011, Research in developmental disabilities.

Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Tristram H. Smith, J. Hellings, X. Pan, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.

C. McDougle, S. Caprio, L. Scahill, 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials

C. McDougle, L. Scahill, E. Butter, 2009, Journal of intellectual & developmental disability.

A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.

Tristram H. Smith, X. Pan, B. Handen, 2018, Journal of child and adolescent psychopharmacology.

Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile

E. Storch, W. Goodman, M. Aman, 2010, Child & youth care forum.

Medication and Parent Training in Children with Pervasive Developmental Disorders and Serious Behavior Problems: Results from a Randomized Clinical Trial Research Units on Pediatric Psychopharmacology Autism Network *

C. McDougle, B. Vitiello, E. Butter, 2011 .

Using qualitative methods to guide scale development for anxiety in youth with autism spectrum disorder

Judith S Miller, R. Whittemore, L. Scahill, 2016, Autism : the international journal of research and practice.